Skip to main content
Clinical Trials/NCT06355440
NCT06355440
Recruiting
N/A

Pilot Study of Financial Navigation Program for Improving Financial Toxicity Among Breast Cancer in China

Fudan University1 site in 1 country24 target enrollmentMarch 18, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Breast Neoplasm Female
Sponsor
Fudan University
Enrollment
24
Locations
1
Primary Endpoint
Eligibility rate
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

The goal of this pilot study is to access the feasibility and impact of a financial navigation program on improving financial toxicity among patients with breast cancer in China.

The main questions it aims to answer are:

  • Is the intervention feasible and acceptable among participants?
  • Does the intervention enhance participants' cost-related health literacy?
  • Does the intervention reduce participants' financial toxicity?

Researchers will compare the financial navigation program with usual oncology care to preliminarily evaluate its effectiveness.

Participants will receive comprehensive information support, including:

  • Strategies on patient-physician costs discussion
  • Skills for inquiring and tracking treatment-related costs
  • Basic knowledge about health insurance
  • Guidance on accessing and applying for financial assistance
  • Suggestions for returning to normal life and work
  • Strategies for holding a financial-related family meeting
Registry
clinicaltrials.gov
Start Date
March 18, 2024
End Date
June 30, 2024
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Xiaoyi Yuan

Principal Investigator

Fudan University

Eligibility Criteria

Inclusion Criteria

  • (1) Newly diagnosed with breast cancer and undergoing surgery during this admission;
  • (2) Female, age 18 years or older;
  • (3) Receiving or expected to receive one or more of the following therapies: chemotherapy, radiotherapy, endocrine therapy, targeted therapy, and immunotherapy;
  • (4) Eastern Cooperative Oncology Group Performance Status 0-2;
  • (5) Provided informed consent to participate in this study.

Exclusion Criteria

  • (1) Diagnosed with ductal carcinoma in situ (DCIS)
  • (2) Presence of any serious psychiatric disorders;
  • (3) Cognitive impairments;
  • (4) Difficulty in reading, writing, or communicating in Chinese.

Outcomes

Primary Outcomes

Eligibility rate

Time Frame: Approximately 1 month

The eligibility rate will be calculated as the proportion of participants who meet the eligibility criteria among the total number of participants who will be assessed for eligibility. Reasons for participants' ineligibility will be recorded.

Consent rate

Time Frame: Approximately 1 month

The consent rate will be calculated as the proportion of eligible participants who consent to participate among those who will be approached and eligible for participation. Reasons for participants' refusal to participate will be recorded.

Attrition rate

Time Frame: Through study completion, an average of 3 month

The attrition rate will be calculated as the percentage of participants who withdraw from or drop out of the study after enrolment. Reasons for participants' withdrawal or dropout will be recorded.

Patient-reported satisfaction

Time Frame: 1 month after discharge in Financial Navigation Arm

Participants' satisfaction will be measured with homemade 5 item questionnaire, with higher scores indicating higher satisfaction.

Adherence rate

Time Frame: Through study completion, an average of 3 month

The adherence rate will be calculated as the proportion of participants completing the entire program. Reasons for participants' nonadherence to the intervention will be recorded.

Qualitative assessment of the intervention

Time Frame: 1 month after discharge in Financial Navigation Arm

Participants' experiences will be captured through one-on-one, semi-structured qualitative interviews.

Secondary Outcomes

  • Material domain of financial toxicity(1st month since baseline)
  • Behavioral domain of financial toxicity(1st month since baseline)
  • Cost-related health literacy(Baseline, 1st month since baseline)
  • Financial toxicity(Baseline, 1st month since baseline)

Study Sites (1)

Loading locations...

Similar Trials